Published • loading... • Updated
Annovis Bio to Present Buntanetap Clinical Data at AD/PD 2026 Conference
Summary by MyChesCo
2 Articles
2 Articles
Annovis Bio to Present Buntanetap Clinical Data at AD/PD 2026 Conference
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced it will present two research updates on its investigational drug buntanetap at the 20th International Conference on Alzheimer’s and Parkinson’s Diseases, scheduled for March 17 through March 21 in Copenhagen, Denmark. The company said the presentations will include clinical data from studies of buntanetap in Parkinson’s disease and an update on its ongoing Phase 3 trial in early-stage Alzhei…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
